Quidel | QDEL - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Abbott USD 2.13B 281M 2026-06
Agilent USD 399M 46M 2026-03
Becton, Dickinson and Co. USD 752M 125M 2026-06
Bruker USD 69.6M 59.4M 2026-06
Cerus USD -1.45M 488K 2024-12
Charles River Laboratories USD 119.89M 9K 2026-06
Danaher USD 1.13B 217M 2026-06
Haemonetics USD 57.46M 5.12M 2026-06
Illumina USD 260M 21M 2026-06
IQVIA Holdings USD 2.6B 2.03B 2026-06
Merit Medical Systems USD 60.4M 16.25M 2026-06
Mettler Toledo International USD 287.55M 53.61M 2026-06
Myriad Genetics USD -3M 20.3M 2025-12
Neogen USD 3.1M 6.4M 2026-03
OraSure Technologies USD -13.59M 2.13M 2025-12
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Quidel USD -15.3M 16.5M 2026-06
Revvity USD 126.14M 43.36M 2026-06
STAAR Surgical USD 10.1M 7.3M 2026-06
Thermo Fisher Scientific USD 2.18B 273M 2026-06
Waters USD -86M 234M 2026-06